NCT01138384 - Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 27, 2010

Primary Completion Date

May 14, 2014

Study Completion Date

February 13, 2015

Conditions

Breast Cancer

Interventions

DRUG

Foretinib

Daily oral dosing at assigned dose beginning day 3 of cycle 1

DRUG

Lapatinib

Daily oral dosing at assigned dose beginning day 1 cycle 1.

Trial Locations (5)

BCCA - Cancer Centre for the Southern Interior, Kelowna

BCCA - Vancouver Cancer Centre, Vancouver

Cancer Centre of Southeastern Ontario at Kingston, Kingston

London Regional Cancer Program, London

McGill University - Dept. Oncology, Montreal